• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate: A Key Compound in Pharmaceutical and Material Sciences

Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate is a fluorinated aromatic ester compound with a unique molecular structure that has garnered significant attention in both pharmaceutical research and material sciences. Its CAS number 1807123-19-8 identifies it as a derivative of 2-methylbenzoic acid, where two trifluoromethyl groups are substituted at the 3 and 5 positions, and a methyl group is attached to the 2-position. This structural feature imparts distinct physicochemical properties, making it a valuable candidate for drug development and functional material applications. Recent studies have highlighted its potential in enhancing bioavailability, modulating biological activity, and improving material stability under various environmental conditions.

The fluorinated functional groups in Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate play a critical role in its chemical behavior. The trifluoromethyl groups (CF₃) are known for their high electronegativity, which influences the molecule's polarity and reactivity. This property is particularly advantageous in drug design, as it can modulate the interaction between the molecule and biological targets. For instance, a 2023 study published in Journal of Medicinal Chemistry demonstrated that compounds with similar fluorinated moieties exhibited improved binding affinity to G-protein-coupled receptors (GPCRs), a class of targets implicated in numerous diseases such as hypertension and schizophrenia.

In the context of pharmaceutical applications, Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate has been explored as a potential prodrug carrier or bioactive molecule. Its ester functionality allows for controlled hydrolysis in biological systems, which can enhance the delivery of therapeutic agents. A 2024 preclinical study conducted by the University of Tokyo investigated its role in improving the solubility and metabolic stability of poorly water-soluble drugs. The results indicated that the compound could significantly prolong the half-life of certain antifungal agents, thereby reducing the frequency of dosing in patients with chronic infections.

From a material science perspective, Methyl 3,5-bis(trifluoromethyl)-y2-methylbenzoate has shown promise in the development of fluoropolymer-based materials. The presence of trifluoromethyl groups enhances the hydrophobicity and thermal stability of polymers, making it suitable for applications in coatings, electronics, and biomedical devices. A recent collaboration between Novartis and MIT (Massachusetts Institute of Technology) explored its use in creating fluorinated nanocomposites for drug delivery systems. These materials demonstrated exceptional resistance to degradation in physiological environments, which is crucial for long-term therapeutic efficacy.

Recent synthetic advancements have further expanded the utility of Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate. Researchers at ETH Zurich developed an efficient asymmetric synthesis route using transition metal-catalyzed coupling reactions, which reduced the number of synthetic steps and improved the overall yield. This method has been particularly useful for scaling up production for industrial applications. Additionally, the compound has been incorporated into library screening efforts to identify novel inhibitors of specific enzymes, such as kinase targets involved in cancer progression.

The environmental impact of Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate has also been a focus of recent research. While its fluorinated structure confers stability, concerns about bioaccumulation and ecotoxicity have prompted studies on its biodegradation pathways. A 2023 report by the European Chemicals Agency (ECHA) highlighted the need for further investigation into its long-term effects on aquatic ecosystems. However, preliminary data suggest that its low solubility in water may mitigate some environmental risks, though this requires validation through comprehensive field studies.

In the realm of drug discovery, Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate has been utilized as a lead optimization candidate. Its structural versatility allows for the introduction of various functional groups to fine-tune pharmacological properties. For example, attaching a hydroxyl group to the methyl substituent has been shown to increase the compound's hydrophilicity, which can improve its permeability across cell membranes. This approach has been tested in in silico models to predict drug-likeness parameters, with promising results for compounds targeting metabolic disorders.

Despite its potential, the synthetic challenges associated with Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate remain a topic of ongoing research. The trifluoromethylation of aromatic rings typically requires harsh conditions, which can lead to side reactions or decomposition of the compound. To address this, researchers have explored electrophilic fluorination methods using fluorinating agents such as fluorosulfuric acid or fluorine gas. However, these methods often involve toxic byproducts, necessitating the development of greener alternatives. A recent breakthrough by Stanford University involved the use of photocatalytic reactions to achieve selective fluorination under mild conditions, offering a more sustainable synthesis pathway.

Looking ahead, the multifunctional applications of Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate are expected to expand further with advances in nanotechnology and biomaterials engineering. Its unique combination of fluorinated groups and ester functionality positions it as a versatile building block for creating smart drugs or responsive materials. For instance, integrating it into hydrogel matrices could enable the controlled release of therapeutics in response to specific stimuli, such as changes in pH or temperature.

In conclusion, Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate represents a promising compound with broad implications across multiple scientific disciplines. Its structural features and functional versatility make it a key player in pharmaceutical innovation and material development. As research continues to uncover its full potential, the compound is likely to play an increasingly important role in addressing complex challenges in health and technology.

Summary of Key Points: 1. Chemical Structure and Properties: - Methyl 3,5-bis(trifluoromethyl)-2-methylbenzoate is a fluorinated aromatic ester with a CAS number of 1807123-19-8. - The presence of trifluoromethyl groups (CF?) at positions 3 and 5, along with a methyl group at position 2, imparts unique electronegativity, polarity, and reactivity. These properties make it valuable for pharmaceutical and material science applications. 2. Pharmaceutical Applications: - Prodrug Carrier: Enhances solubility and metabolic stability of poorly water-soluble drugs. - GPCR Modulation: Studies show improved binding affinity to G-protein-coupled receptors, relevant for diseases like hypertension and schizophrenia. - Drug Delivery Systems: Used in fluorinated nanocomposites for sustained release of therapeutics. 3. Material Science Applications: - Fluoropolymer Development: Enhances hydrophobicity and thermal stability, suitable for coatings, electronics, and biomedical devices. - Smart Materials: Integration into hydrogels for stimuli-responsive drug delivery (e.g., pH or temperature-sensitive release). 4. Synthetic Advancements: - Efficient Synthesis: Transition metal-catalyzed coupling reactions reduce synthetic steps and improve yield. - Sustainable Methods: Photocatalytic reactions offer greener alternatives for selective fluorination. 5. Environmental Considerations: - Low Water Solubility: Mitigates some environmental risks, though further studies are needed on bioaccumulation and ecotoxicity. 6. Future Prospects: - Multifunctional Applications: Potential in nanotechnology and biomaterials engineering. - Innovation: Continued research may unlock new roles in healthcare and technology, addressing complex challenges. Conclusion: The compound's structural versatility and functional properties position it as a key player in pharmaceutical innovation and material development, with significant potential for future advancements.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)